Literature DB >> 21345947

Cytomegalovirus UL103 controls virion and dense body egress.

Jenny Ahlqvist1, Edward Mocarski.   

Abstract

Human cytomegalovirus UL103 encodes a tegument protein that is conserved across herpesvirus subgroups. Mutant viruses lacking this gene product exhibit dramatically reduced accumulation of cell-free virus progeny and poor cell-to-cell spread. Given that viral proteins and viral DNA accumulate with normal kinetics in cells infected with mutant virus, UL103 appears to function during the late phase of replication, playing a critical role in egress of capsidless dense bodies and virions. Few dense bodies were observed in the extracellular space in mutant virus-infected cells in the presence or absence of the DNA encapsidation inhibitor 2-bromo-5,6-dichloro-1-(β-d-ribofuranosyl)benzimidazole. Upon reversal of encapsidation inhibition, UL103 had a striking impact on accumulation of cell-free virus, but not on accumulation of cell-associated virus. Thus, UL103 plays a novel and important role during maturation, regulating virus particle and dense body egress from infected cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21345947      PMCID: PMC3126192          DOI: 10.1128/JVI.01682-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Functional map of human cytomegalovirus AD169 defined by global mutational analysis.

Authors:  Dong Yu; Maria C Silva; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

2.  Human cytomegalovirus morphogenesis: an ultrastructural study of the late cytoplasmic phases.

Authors:  B Severi; M P Landini; E Govoni
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Nonviral microbodies with viral antigenicity produced in cytomegalovirus-infected cells.

Authors:  J E Craighead; R E Kanich; J D Almeida
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

4.  Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus.

Authors:  A Irmiere; W Gibson
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

5.  Envelopment of human cytomegalovirus occurs by budding into Golgi-derived vacuole compartments positive for gB, Rab 3, trans-golgi network 46, and mannosidase II.

Authors:  M Homman-Loudiyi; K Hultenby; W Britt; C Söderberg-Nauclér
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  Virus inhibition of RIP3-dependent necrosis.

Authors:  Jason W Upton; William J Kaiser; Edward S Mocarski
Journal:  Cell Host Microbe       Date:  2010-04-22       Impact factor: 21.023

7.  Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response.

Authors:  Davide A Abate; Shinya Watanabe; Edward S Mocarski
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome.

Authors:  Susan M Varnum; Daniel N Streblow; Matthew E Monroe; Patricia Smith; Kenneth J Auberry; Ljiljana Pasa-Tolic; Dai Wang; David G Camp; Karin Rodland; Steven Wiley; William Britt; Thomas Shenk; Richard D Smith; Jay A Nelson
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Human cytomegalovirus TRS1 protein is required for efficient assembly of DNA-containing capsids.

Authors:  Joan E Adamo; Jörg Schröer; Thomas Shenk
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Functional profiling of a human cytomegalovirus genome.

Authors:  Walter Dunn; Cassie Chou; Hong Li; Rong Hai; David Patterson; Viktor Stolc; Hua Zhu; Fenyong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

View more
  27 in total

1.  Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes.

Authors:  Shinya Omoto; Edward S Mocarski
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

2.  Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids.

Authors:  Ritesh Tandon; Edward S Mocarski
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

3.  The herpes simplex virus 1 UL51 protein interacts with the UL7 protein and plays a role in its recruitment into the virion.

Authors:  Richard J Roller; Rachel Fetters
Journal:  J Virol       Date:  2014-12-31       Impact factor: 5.103

4.  A Portrait of the Human Organelle Proteome In Space and Time during Cytomegalovirus Infection.

Authors:  Pierre M Jean Beltran; Rommel A Mathias; Ileana M Cristea
Journal:  Cell Syst       Date:  2016-09-15       Impact factor: 10.304

5.  Interaction of Human Cytomegalovirus Tegument Proteins ppUL35 and ppUL35A with Sorting Nexin 5 Regulates Glycoprotein B (gpUL55) Localization.

Authors:  Gregor Maschkowitz; Sabine Gärtner; Heike Hofmann-Winkler; Helmut Fickenscher; Michael Winkler
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

6.  Quantitative Electron Microscopy to Study HCMV Morphogenesis.

Authors:  Clarissa Read; Paul Walther; Jens von Einem
Journal:  Methods Mol Biol       Date:  2021

Review 7.  Viral and host control of cytomegalovirus maturation.

Authors:  Ritesh Tandon; Edward S Mocarski
Journal:  Trends Microbiol       Date:  2012-05-23       Impact factor: 17.079

8.  The Interaction between Herpes Simplex Virus 1 Tegument Proteins UL51 and UL14 and Its Role in Virion Morphogenesis.

Authors:  Shinya Oda; Jun Arii; Naoto Koyanagi; Akihisa Kato; Yasushi Kawaguchi
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

9.  Protein-Protein Interactions Suggest Novel Activities of Human Cytomegalovirus Tegument Protein pUL103.

Authors:  Daniel A Ortiz; James E Glassbrook; Philip E Pellett
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

10.  Identification of human cytomegalovirus genes important for biogenesis of the cytoplasmic virion assembly complex.

Authors:  Subhendu Das; Daniel A Ortiz; Stephen J Gurczynski; Fatin Khan; Philip E Pellett
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.